Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.

McCart EA, Lee YH, Jha J, Mungunsukh O, Rittase WB, Summers TA Jr, Muir J, Day RM.

Sci Rep. 2019 Feb 18;9(1):2198. doi: 10.1038/s41598-019-38651-2.

2.

Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis.

Corey SJ, Jha J, McCart EA, Rittase WB, George J, Mattapallil JJ, Mehta H, Ognoon M, Bylicky MA, Summers TA, Day RM.

J Cell Mol Med. 2018 Sep;22(9):4274-4282. doi: 10.1111/jcmm.13710. Epub 2018 Jul 4.

3.

Midkine and pleiotrophin concentrations in needle biopsies of breast and lung masses.

Giamanco NM, Jee YH, Wellstein A, Shriver CD, Summers TA, Baron J.

Cancer Biomark. 2017 Sep 7;20(3):299-307. doi: 10.3233/CBM-170145.

4.

Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.

Miller B, Lustberg M, Summers TA, Chalmers JJ.

Methods Mol Biol. 2017;1634:219-234. doi: 10.1007/978-1-4939-7144-2_19.

PMID:
28819855
5.

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

Brzezniak C, Oronsky B, Trepel J, Summers TA Jr, Cabrales P, Lee MJ, Day R, Jha S, Caroen S, Zeman K, Ferry L, Harmer C, Oronsky N, Lybeck M, Lybeck HE, Brown JF, Reid TR, Carter CA.

Case Rep Oncol. 2017 Mar 29;10(1):276-280. doi: 10.1159/000464101. eCollection 2017 Jan-Apr.

6.

RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.

Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA Jr, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, Kesari S, Abrouk ND, Day RM, Oronsky A, Ray CM, Carter CA.

Expert Opin Investig Drugs. 2017 Jan;26(1):109-119. doi: 10.1080/13543784.2017.1268600. Review. Erratum in: Expert Opin Investig Drugs. 2017 Feb;26(2):261. Carterg, Corey A [corrected to Carter, Corey A].

7.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

8.

The tug sign: an endoscopic feature of eosinophilic esophagitis.

Moawad FJ, Robinson CL, Veerappan GR, Summers TA, Maydonovitch CL, Wong RKh.

Am J Gastroenterol. 2013 Dec;108(12):1938-9. doi: 10.1038/ajg.2013.252. No abstract available.

PMID:
24300877
9.

Splenic manifestations of chronic autoimmune disorder: a report of five cases with histiocytic necrotizing change in four cases.

Auerbach A, Summers TA, Zhang B, Aguilera NS.

Histopathology. 2013 Jul;63(1):19-28. doi: 10.1111/his.12143. Epub 2013 May 15.

PMID:
23672439
10.

Colorectal cancer stem cells as biomarkers: where it all starts?

Avital I, Summers TA, Steele SR, Waldman S, Nissan A, Bilchik AJ, Protic M, Man YG, BrĂ¼cher BL, Stojadinovic A.

J Surg Oncol. 2013 Jun;107(8):791-3. doi: 10.1002/jso.23330. Epub 2013 Mar 19. No abstract available.

PMID:
23512573
11.

Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions.

Avital I, Langan RC, Summers TA, Steele SR, Waldman SA, Backman V, Yee J, Nissan A, Young P, Womeldorph C, Mancusco P, Mueller R, Noto K, Grundfest W, Bilchik AJ, Protic M, Daumer M, Eberhardt J, Man YG, BrĂ¼cher BL, Stojadinovic A.

J Cancer. 2013;4(3):172-92. doi: 10.7150/jca.5834. Epub 2013 Mar 1.

12.

Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.

Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA Jr, Lustberg MB, Zborowski M, Chalmers JJ.

PLoS One. 2012;7(7):e42048. doi: 10.1371/journal.pone.0042048. Epub 2012 Jul 26.

13.

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.

Eberle FC, Salaverria I, Steidl C, Summers TA Jr, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES.

Mod Pathol. 2011 Dec;24(12):1586-97. doi: 10.1038/modpathol.2011.116. Epub 2011 Aug 5.

14.

Consensus recommendations for advancing breast cancer: risk identification and screening in ethnically diverse younger women.

Stojadinovic A, Summers TA, Eberhardt J, Cerussi A, Grundfest W, Peterson CM, Brazaitis M, Krupinski E, Freeman H.

J Cancer. 2011 Apr 20;2:210-27.

15.

Hairy cell leukemia diagnostic criteria and differential diagnosis.

Summers TA, Jaffe ES.

Leuk Lymphoma. 2011 Jun;52 Suppl 2:6-10. doi: 10.3109/10428194.2011.565435. Epub 2011 Mar 21. Review.

16.

The small cell variant of anaplastic large cell lymphoma.

Summers TA, Moncur JT.

Arch Pathol Lab Med. 2010 Nov;134(11):1706-10. doi: 10.1043/2008-0624-RSR.1. Review.

PMID:
21043827
17.

Cutaneous involvement in the lymphoepithelioid variant of peripheral T-cell lymphoma, unspecified (Lennert lymphoma). Report of a case and review of the literature.

Summers TA Jr, Rush W, Aguilera N, Lupton G.

J Cutan Pathol. 2009 Oct;36 Suppl 1:25-30. doi: 10.1111/j.1600-0560.2008.01203.x. Review.

PMID:
19775391
18.

Lupus mastitis: a clinicopathologic review and addition of a case.

Summers TA Jr, Lehman MB, Barner R, Royer MC.

Adv Anat Pathol. 2009 Jan;16(1):56-61. doi: 10.1097/PAP.0b013e3181915ff7. Review.

PMID:
19098467
19.

Critical policy challenges in the third decade of the HIV/AIDS epidemic.

Kates J, Sorian R, Crowley JS, Summers TA.

Am J Public Health. 2002 Jul;92(7):1060-3.

20.

Expression and distribution of leptospiral outer membrane components during renal infection of hamsters.

Barnett JK, Barnett D, Bolin CA, Summers TA, Wagar EA, Cheville NF, Hartskeerl RA, Haake DA.

Infect Immun. 1999 Feb;67(2):853-61.

21.

Characterization of leptospiral outer membrane lipoprotein LipL36: downregulation associated with late-log-phase growth and mammalian infection.

Haake DA, Martinich C, Summers TA, Shang ES, Pruetz JD, McCoy AM, Mazel MK, Bolin CA.

Infect Immun. 1998 Apr;66(4):1579-87.

22.

Heat shock response and groEL sequence of Bartonella henselae and Bartonella quintana.

Haake DA, Summers TA, McCoy AM, Schwartzman W.

Microbiology. 1997 Aug;143 ( Pt 8):2807-15.

PMID:
9274034
24.

The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin.

Shang ES, Exner MM, Summers TA, Martinich C, Champion CI, Hancock RE, Haake DA.

Infect Immun. 1995 Aug;63(8):3174-81.

25.

Worsening right flank pain over a 24-hr period.

Summers TA, Fultz PJ, Sacks D.

Acad Radiol. 1994 Oct;1(2):194-8. Review.

PMID:
9419486
26.

The value of duplex sonography after peripheral artery angioplasty in predicting subacute restenosis.

Sacks D, Robinson ML, Summers TA, Marinelli DL.

AJR Am J Roentgenol. 1994 Jan;162(1):179-83.

PMID:
8273660
27.
28.

Antegrade selective catheterization of femoral vessels with a 4- or 5-F catheter and safety wire.

Sacks D, Summers TA.

J Vasc Interv Radiol. 1991 Aug;2(3):325-6.

PMID:
1799774
29.

Dynamics of a human seminal vesicle specific protein.

Flickinger CJ, Herr JC, McGee RS, Sigman M, Evans RJ, Sutherland WM, Summers TA, Spell DR, Conklin DJ.

Andrologia. 1990;22 Suppl 1:142-54. Review.

PMID:
1720288
30.

Monoclonal antibodies to type X collagen. Biosynthetic studies using an antibody to the amino-terminal domain.

Summers TA, Irwin MH, Mayne R, Balian G.

J Biol Chem. 1988 Jan 5;263(1):581-7.

31.
32.

Phosphorylation of a chromaffin granule-binding protein by protein kinase C.

Summers TA, Creutz CE.

J Biol Chem. 1985 Feb 25;260(4):2437-43.

Supplemental Content

Loading ...
Support Center